Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 410.69B | 421.67B | 370.68B | 417.62B | 462.82B | 302.38B |
Gross Profit | 15.65B | 14.70B | 13.67B | 16.14B | 14.33B | 7.86B |
EBITDA | 7.80B | 9.51B | 4.23B | 8.15B | 8.74B | 4.69B |
Net Income | 6.06B | 5.59B | 2.10B | 4.91B | 6.38B | 3.45B |
Balance Sheet | ||||||
Total Assets | 160.56B | 113.97B | 130.21B | 107.18B | 116.99B | 119.89B |
Cash, Cash Equivalents and Short-Term Investments | 15.22B | 5.80B | 20.86B | 7.49B | 6.71B | 3.20B |
Total Debt | 45.87B | 14.05B | 29.66B | 20.56B | 9.50B | 14.60B |
Total Liabilities | 110.66B | 64.35B | 84.70B | 62.98B | 77.63B | 87.09B |
Stockholders Equity | 49.90B | 49.62B | 45.51B | 43.21B | 38.59B | 32.17B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 9.20B | 4.15B | -5.25B | 5.74B | -11.61B |
Operating Cash Flow | 0.00 | 9.21B | 4.42B | -4.96B | 5.90B | -11.58B |
Investing Cash Flow | 0.00 | -21.00M | 494.00M | -263.00M | -183.00M | -30.00M |
Financing Cash Flow | 0.00 | -16.85B | 2.90B | 8.58B | -7.60B | 11.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥38.65B | 8.67 | 3.83% | 7.88% | 39.72% | ||
77 Outperform | ¥40.60B | 7.26 | 5.03% | 13.76% | 166.61% | ||
77 Outperform | ¥29.01B | 10.96 | 3.62% | -0.38% | 6.16% | ||
77 Outperform | ¥28.69B | 8.30 | 1.76% | 36.47% | 454.90% | ||
73 Outperform | ¥27.13B | 12.32 | 5.58% | 6.47% | -6.67% | ||
62 Neutral | £504.35M | 24.87 | -8.56% | 2.49% | 4.03% | -28.20% | |
56 Neutral | ¥33.50B | 487.33 | 6.04% | -46.16% | -98.25% |